Filing Flows › Alpha Teknova (TKNO) › How it makes money
How Alpha Teknova (TKNO) makes money
Alpha Teknova (TKNO) made $12.7M of revenue in the third quarter 2026 (Q3 2026), +22% from a year earlier. Lab Essentials brought in $9.0M (71%); Clinical Solutions brought in $3.2M (25%); Other Product brought in $502K (4%).
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Lab Essentials | $9.0M | 71.1% | -2% | +9% |
| Clinical Solutions | $3.2M | 24.9% | +30% | +86% |
| Other Product | $502K | 4.0% | -12% | +14% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $12.7M | 100.0% |
| Income tax | $34K | 0.3% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $12.7M | +22% |
| Q2 2026 | $12.2M | +18% |
| Q1 2026 | $11.1M | +13% |
| Q4 2025 | $10.0M | +8% |
| Q3 2025 | $10.5M | +9% |
| Q2 2025 | $10.3M | +7% |
| Q1 2025 | $9.8M | +5% |
From Alpha Teknova's 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Alpha Teknova make money?
Alpha Teknova (TKNO) made $12.7M of revenue in the third quarter 2026 (Q3 2026), +22% from a year earlier. Lab Essentials brought in $9.0M (71%); Clinical Solutions brought in $3.2M (25%); Other Product brought in $502K (4%).
What is Alpha Teknova's biggest business?
Lab Essentials: $9.0M in the third quarter 2026, 71% of revenue, +9% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.